EuroIntervention PCRonline - Connecting with the community

ahead of print

Towards Drugs and Devices Synergy. A new session track at EuroPCR: PCR clinical algorithms

1. FACT, French Alliance for Cardiovascular Trials; Hôpital Bichat, AP-HP; Université Paris-Diderot; and INSERM U-1148, all in Paris, France; 2. Royal Brompton Hospital, Imperial College London, London, United Kingdom; 3. University of Galway, Galway, Ireland

Steg_PhilippeGabriel_Portrait.tif

There have been truly incredible advances in clinical and interventional cardiology over recent decades. We have gone from an era where we really did not have effective therapies for many cardiac conditions to an era where the pharmacological and interventional armamentarium has become so rich that selecting the proper combination becomes the issue. In addition, specific problems have emerged in interventional cardiology regarding the understanding and delivery of “best pharmacological care” in patients treated with devices. There is a myriad of possible combinations of drugs and devices in terms…

– OR –

Authors